More than 40 seed and early stage companies took to the showroom floor at this year’s mHealth Summit in Washington D.C., which ended Wednesday. Many were sponsored by incubators including StartUp Health and Rock Health. This is one of a series of posts I’m publishing that includes elevator pitches from 10 of the companies I liked.
CareSpeak Communications
East Brunswick, New Jersey company CareSpeak Communications develops wireless communications technologies for the institutional and consumer healthcare markets. It developed a two-way text-message communications platform for health care apps and started a partnership with with UnitedHealth in September. Among its apps are reminders for patients to take their medication on time, a specialized app for diabetics to monitor glucose and insulin levels and the ability for physicians to communicate with patients.
Behavioral Health, Interoperability and eConsent: Meeting the Demands of CMS Final Rule Compliance
In a webinar on April 16 at 1pm ET, Aneesh Chopra will moderate a discussion with executives from DocuSign, Velatura, and behavioral health providers on eConsent, health information exchange and compliance with the CMS Final Rule on interoperability.
In addition to UnitedHealth (NYSE: UNH), other partners include The Apothecary Shops and Everyday Health. It collaborates with Mount Sinai Medical Center, Children’s National Medical Center in Washington, D.C., Morgan Stanley Children’s Hospital of New York-Presbyterian.
It was sponsored in the mHealth startup pavilion by StartUp Health.
“CareSpeak is a disease management software platform that uses two-way text messaging to remind people to take their medication,” said Srdjan Serge Loncar, the CEO. “One of the issues we have is that one quarter to one third of people never fill their scripp. So the doctor tells them when they sign up they will get educational factoid messages and once they respond that they did we could set them up on a variety of therapies.”
A Deep-dive Into Specialty Pharma
A specialty drug is a class of prescription medications used to treat complex, chronic or rare medical conditions. Although this classification was originally intended to define the treatment of rare, also termed “orphan” diseases, affecting fewer than 200,000 people in the US, more recently, specialty drugs have emerged as the cornerstone of treatment for chronic and complex diseases such as cancer, autoimmune conditions, diabetes, hepatitis C, and HIV/AIDS.
Read about the other nine startups: Above Stress, HealthTap, EnHatch, Meddik, ScriptPad, Force Therapeutics, OrganizedWisdom, Ayogo and Beyond Lucid Technologies.
